Cardinal Health 303 Inc Agrees to Correct GMP Violations

The Food and Drug Administration announced recently that California device manufacturer Cardinal Health 303 Inc., formerly known as Alaris Medical Systems Inc., and three of its top executives have signed an amended consent decree to correct violations of current Good Manufacturing Practice (cGMP) requirements in the company's infusion pumps.

Infusion pumps are devices intended for controlled delivery of intravenous solutions and medications to patients.

Under the terms of the amended consent decree, Cardinal 303 agrees to comply with the cGMP requirements and Quality System (QS) regulations in the designing, manufacturing, processing, packing, repacking, labeling, holding, or distributing of its infusion pumps. Cardinal 303 also must retain an independent expert consultant to inspect of all of its infusion pump facilities and recall procedures, and certify to FDA that corrections have been made. Additionally, the company must submit to FDA a detailed corrective action plan to bring all infusion pumps currently in use in the United States into compliance with the Federal Food, Drug, and Cosmetic Act (FDCA).

The decree covers all of the company's infusion pumps, including the Alaris System (formerly known as Medley) infusion pump, the Gemini infusion pump, and the Med System III infusion pump.

In August 2006, U.S. Marshals seized certain models of Cardinal 303's Alaris SE (formerly known as the Signature Edition) line of infusion pumps at the company's manufacturing facility in San Diego. Subsequently, in 2007, Cardinal 303 signed a consent decree in which they agreed to cease manufacturing, processing, or distributing the Alaris SE line of infusion pumps until the company corrected deviations from the QS regulations. Cardinal 303 is still in the process of making these corrections.

After the company signed the consent decree related to the SE line, FDA investigators found similar QS deviations relating to another line of Cardinal 303's infusion pumps. Among the deficiencies was a failure to notify FDA in a timely manner after becoming aware that one of the company's infusion pumps had malfunctioned and that the device would be likely to cause or contribute to death or serious injury if the malfunction were to recur. Cardinal 303 also failed to establish and maintain procedures to review, evaluate, and investigate complaints of malfunction or failure of its pumps. Based on these violations, FDA sought to amend the 2007 decree to cover all of Cardinal 303's infusion pumps.

Once Cardinal 303 makes the corrective actions specified in the decree, the company must hire an independent auditor to conduct annual audit inspections of all of its infusion pump facilities for at least four years and report the results to the FDA.

In the event of future violations, the amended consent decree also authorizes FDA to order Cardinal 303 to cease manufacturing and distributing, to recall products, and to take other actions. The defendants may be required to pay damages of $15,000 per day if they fail to comply with any provisions of the decree, plus an additional $15,000 for each violation, up to $15 million per year.

The amended consent decree was filed on Feb. 18 in the U.S. District Court for the Southern District of California and is effective when entered by the court. The terms of the 2007 consent decree are still in effect.

Product Showcase

  • Magid® D-ROC® GPD412 21G Ultra-Thin Polyurethane Palm Coated Work Gloves

    Magid’s 21G line is more than just a 21-gauge glove, it’s a revolutionary knitting technology paired with an advanced selection of innovative fibers to create the ultimate in lightweight cut protection. The latest offering in our 21G line provides ANSI A4 cut resistance with unparalleled dexterity and extreme comfort that no other 21-gauge glove on the market can offer! Read More

  • Safety Knives

    The Safety Knife Company has developed a quality range of safety knives for all industries. Designed so that fingers cannot get to the blades, these knives will safely cut through cardboard, tape, strapping, shrink or plastic wrap or a variety of other packing materials. Because these knives have no exposed blades and only cut cardboard deep, they will not only protect employees against lacerations but they will also save product. The Metal Detectable versions have revolutionary metal detectable polypropylene knife bodies specifically for the food and pharmaceutical industries. This material can be detected and rejected by typical detection machines and is X-ray visible. Read More

  • HAZ LO HEADLAMPS

    With alkaline or rechargeable options, these safety rated, Class 1, Div. 1 Headlamps provide long runtime with both spot and flood options in the same light. Work safely and avoid trip hazards with flexible hands-free lighting from Streamlight. Read More

Featured

Artificial Intelligence

Webinars